What are you looking for today?

Attia, Mohamed, Hill, David, Chaw, Cheng and Elkordy, Amal (2025) Novel combinational nanomedicines, liposomes, to tackle breast cancer. Journal of Microencapsulation. pp. 1-24. ISSN 0265-2048

Document

Abstract

Abstract

Aims: Doxorubicin (DOX), a potent chemotherapeutic, is a commonly prescribed treatment for breast cancer, but is limited by severe organ toxicity. Therefore, more effective therapies are required. This study developed a novel DOX-liposomes (LipDOX-ALA-AA) co-loaded with alpha-lipoic-acid (ALA) and ascorbic-acid (AA) to enhance antineoplastic effect.
Methods: Liposomes were fabricated using a microfluidic-system with a DSPClipid:Cholesterol ratio of 1:1 and a flow rate ratio of 5:1. Liposomes were investigated using various-techniques such-as dynamic light scattering to measure liposomes’ size and charge; and UV-spectroscopy to determine DOX-encapsulation-efficiency, EE. Cytotoxicity assays used various cell-lines.
Results: Data revealed that LipDOX-ALA-AA had diameter of 79.0 ± 0.3 nm, with narrow size distribution, and zeta-potential of −4.0 ± 1.2. DOX-EE exceeded 95%, drug load was 0.5 mg/105.5 mg total content, drug release followed a biphasic pattern. Cytotoxicity assay showed activity (p < 0.05) against breast cancer cell-lines with reduced nephrotoxicity compared to Doxosome.
Conclusion: This novel formulation (LipDOX-ALA-AA) offers a promise in breast cancer therapy.

Item Type: Article
Additional Information: This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Microencapsulation on 04/04/2025, available at: https://doi.org/10.1080/02652048.2025.2487031.
Uncontrolled Keywords: Liposomes, reactive oxygen species, doxorubicin, antioxidants, alpha-lipoic acid, ascorbic acid, apoptosis, breast cancer.
Depositing User: Amal Elkordy
URI: https://sure.sunderland.ac.uk/id/eprint/18957

Further Details

More Information

Additional Information
This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Microencapsulation on 04/04/2025, available at: https://doi.org/10.1080/02652048.2025.2487031.
Uncontrolled Keywords
Liposomes, reactive oxygen species, doxorubicin, antioxidants, alpha-lipoic acid, ascorbic acid, apoptosis, breast cancer.
Depositing User

Identifiers

Item ID
18957
Identification Number
ISSN
0265-2048

Users with ORCIDS

ORCID for Mohamed Attia
ORCID for David Hill
ORCID for Cheng Chaw
ORCID for Amal Elkordy

Catalogue record

Date Deposited
17 Apr 2025 11:06
Last Modified
04 Apr 2026 02:38

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year